• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Business Research >What drives biopharmaceutical firms' exploratory openness? A comparative process tracing approach to the analysis of R&D microfoundations
【24h】

What drives biopharmaceutical firms' exploratory openness? A comparative process tracing approach to the analysis of R&D microfoundations

机译：是什么驱动生物制药公司的探索性开放？研发微观基础分析的比较过程跟踪方法

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

By responding to the call for a multidimensional approach in the open innovation domain, the present work aims to clarify the interplay of different internal R&D resources as microfoundations through which exploratory openness is encouraged and enacted.By combining the use of fuzzy- set qualitative comparative analysis (fsQCA) and process tracing, we undertake an in-depth analysis of specific causal mechanisms, linking a combination of internal R&D resources to predicting biopharmaceutical exploratory openness. In line with the theoretical framework, the breadth and depth of the firm knowledge base were translated into three different sources of diversity, which represent the three fsQCA conditions: R&D team composition, corporate research relationships, and R&D resource allocation.The study reveals that diversity in R&D resources contributes in a multifaceted way to firms' exploratory openness and is determined by the interactions among different dimensions of diversity.
机译：通过回应开放式创新领域对多维方法的呼吁，本工作旨在阐明不同内部研发资源作为微观基础的相互作用，从而鼓励和制定探索性开放性。通过结合使用模糊集定性比较分析（fsQCA）和过程跟踪，我们对特定的因果机制进行了深入分析，将内部研发资源的组合与预测生物制药探索性开放性联系起来。根据理论框架，将企业知识库的广度和深度转化为三种不同的多样性来源，它们代表了fsQCA的三个条件：研发团队组成，企业研究关系和研发资源分配。 R＆D中的资源以多方面的方式促进了企业的探索性开放，并由多样性的不同维度之间的相互作用所决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号